Aggravation of epilepsy by anti-epileptic drugs

Developmental Medicine and Child Neurology

Volumn 48, Issue 5, 2006, Pages 394-398

  Gayatri, Neti A ^a,b   Livingston, J H ^a  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

BENIGN CHILDHOOD EPILEPSY; BRAIN DISEASE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG INDUCED DISEASE; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMAN; LENNOX GASTAUT SYNDROME; MYOCLONUS EPILEPSY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEDATION; SIDE EFFECT;

ANTICONVULSANTS; CHILD; EPILEPSY; HUMANS; PREVALENCE; SEVERITY OF ILLNESS INDEX;

EID: 33645778797     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1017/S0012162206000843     Document Type: Review

References (45)

1. Pirmohamed M, Park BK. (2001) Genetic susceptibility to adverse drug reactions. Trends Pharmacol Sci 22: 298-305.
2. Papini M, Pasquinelli A, Armellini M, Orlandi D. (1984) Alertness and incidence of seizures in patients with Lennox Gastaut syndrome. Epilpepsia 25: 161-167.
3. Alvarez N, Hartford E, Doubt C. (1981) Epileptic seizures induced by clonazepam. Clin Electroencephalogr 12: 57-65.
4. Vallarta JM, Bell DB, Reichert A. (1974) Progressive encephalopathy due to chronic hydantoin intoxication. Am J Dis Child 128: 27-34.
5. Osorio I, Burnstine H, Remler B, Manon-Espaillat R, Reed RC. (1989) Phenytoin induced seizures: A paradoxical effect at toxic concentrations in epileptic patients. Epilepsia 30: 230-234.
6. So EL, Ruggles KH, Cascino GD, Ahmann PA, Weatherford KW. (1994) Seizure exacerbation and status epilepticus related to carbamazepine-10,11-epoxide. Ann Neurol 35: 743-746.
7. Salke-Kellerman A, Baier H, Rambeck B, Boenigk HE, Wolf P. (1993) Acute encephalopathy with vigabatrin. Lancet 342: 185.
8. Smith CR. (1991) Encephalopathy as an idiosyncratic reaction to carbamazepine: A case report. Neurology 41: 760-761.
9. Neumann B, Steinoff BJ. (1994) Die Carbamazepin-Encephalopathie: Eine selteen Nebenwirkung. Aktuel Neurol 21: 191-194.
10. Bauer J. (1996) Seizure inducing effects of antiepileptic drugs: A review. Acta Neurol Scand 94: 367-377.
11. Pakalnis A, Drake ME, Denio L. (1989) Valproate-associated encephalopathy. J Epilepsy 2: 41-44.
12. Rangel RJ, Warner JJ, Wilder BJ. (1988) Valproic acid encephalopathy. J Epilepsy 1: 197-202.
13. Horn CS, Ater SB, Hurst DL. (1986) Carbamazepine exacerbated epilepsy in children and adolescents. 2: 340-345.
14. Nanba Y, Maegaki Y. (1999) Epileptic negative myoclonus induced by carbamazepine in a child with BECTS. Pediatr Neurol 21: 664-667.
15. Snead OC, Horsey LC. (1985) Exacerbation of seizures in children by carbamazepine. N Engl J Med 313: 916-921.
16. Lortie A, Chiron C, Mumford J, Dulac O. (1993) The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin. Neurology 43 (Suppl. 5): S24-S27.
17. Wilder BJ, Bruni J. (1981) Barbiturates: Phenobarbital, mephobarbital and metharbital. In: Wilder BJ, Bruni J, eAitors. Seizure Disorders: a Pharmacological Approach to Treatment. New York: Raven Press. p 47-60.
18. Guerrini R, Dravet C, Genton P, Belmonte A, Kamiska A, Dulac O. (1998) Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia 39: 508-512.
19. Vossler DG. (1996) Exacerbation of seizures in Lennox Gestaut syndrome by Gabapentin. Neurology 46: 852-853.
20. Eldridge R, Iivanainen M, Stern R, Koerber T. (1983) 'Baltic' myoclonus epilepsy: Hereditary disorder of childhood made worse by phenytoin. Lancet ii: 838-842.
21. Viani F, Romeo A, Viri M, Mastrangelo M, Lalatta F, Selicorni A, Gobbi G, Lanzi G, Bettio D, Briscioli V. (1995) Seizure and EEG patterns in Angelman's syndrome. J Child Neurol 10: 467-471.
22. Aicardi J, Chevrie JJ. (1982) Atypical benign epilepsy in childhood. Dev Med Child Neurol 24: 281-292.
23. Arzimanoglou A, Guerrini R, Aicardi J. (2004) Aypical benign partial epilepsy of childhood. In: Arzimanoglou A, Guerrini R, Aicardi J, editors. Aicardi's Epilepsy in Children. 3rd edn. Philadelphia: Lippincott Williams & Wilkins, p 152-155.
24. Marescaux C, Hirsch E, Finck S, Maquet P, Schlumberger E, Sellal F, Metz-Lutz MN, Alembik Y, Salmon E, Franck G. (1990) Landau-Kleffner syndrome: A pharmacological study of five cases. Epilepsia 31: 768-777.
25. Dhuna A, Pascual-Leone A, Talwar D. (1991) Exacerbation of partial seizures and onset of non-epileptic myoclonus with carbamazepine. Epilepsia 32: 275-278.
26. Vallarta JM, Bell DB, Reichert A. (1974) Progressive encephalopathy due to chronic hydantoin intoxication. Am J Dis Child 128: 27-34.
27. Catania S, Cross H, de Sousa C, Boyd S. (1999) Paradoxic reaction to lamotrigine in a child with benign focal epilepsy of childhood with centrotemporal spikes. Epilepsia 40: 1657-1660.
28. Guerrini R, Belmonte A, Parmeggiani L, Perucca E. (1999) Myoclonic status epilepticus following high dose lamotrigine therapy. Brain Dev 21: 420-424.
29. Trinka E, Dilitz E, Unterberger I, Luef G, Deisenhammer F, Neidermuller U, Thaler C, Bauer G. (2002) Non convulsive status epilepticus after replacement of valproate with lamotrigine. J Neurol 249: 1417-1422.
30. Tassinari CA, Dravet C, Roger J, Cano JP, Gastaut H. (1972) Tonic status epilepticus precipitataed by intravnous benzodiazepine in five patients with Lennox-Gastaut Syndrome. Epilepsia 13: 421-435.
31. Prior PF, Maclaine GN, Scott DF, Laurance BM. (1972) Tonic status epilepticus precipitated by intravenous diazepam in a child with petit mal status. Epilepsia 13: 467-472.
32. Di Mario FJ Jr, Calancy RR. (1988) Paradoxical precipitation of tonic seizures by lorazepam in a child with atypical absence seizures. Pediatr Neurol 4: 249-251.
33. Livingston JH, Brown JK. (1987) Non convulsive status epilepticus resistant to benzodiazepines. Arch Dis Child 62: 41-44.
34. Tassinari CA, Daniele O, Michelucci R, Bureau M, Dravet C, Roger J. (1983) Benzodiazepines: Efficacy in status epilepticus. In: Delgado-Escueta AV, Wasterlain CG, Treiman DM, Porter RJ, editors. Status Epilepticus. Mechanisms of Brain Damage and Treatment. New York: Raven Press. p 465-476.
35. Marciani MG, Maschio M, Spanedda F, Iani C, Gigli GL, Bernardi G. (1995) Development of myoclonus in patients with partial epilepsy during treatment with vigabatrin: An electroencephalographic study. Acta Neurol Scan 91: 1-5.
36. Asconape J, Diedrich A, Della Badia J. (2000) Myoclonus associated with the use of Gabapentin. Epilepsia 41: 479-481.
37. Vossler DG. (1996) Exacerbation of seizures in Lennox Gastaut syndrome by Gabapentin. Neurology 46: 852-853.
38. Trinka E, Moroder T, Naegler M, Staffen W, Loscher W, Ladurner G. (1999) Clinical and EEG findings in complex partial status epilepticus with tiagabine. Seizure 8: 41-44.
39. Knake S, Hamer HM, Schomburg U, Oertel WH, Rosenow F. (1999) Tiagabine induced absence status in idiopathic generalized epilepsy. Seizure 8: 314-317.
40. Suzdak PD, Jansen JA. (1995) A review of the preclinical pharmacology of tiagabine: A potent and selective anticonvulsant GABA uptake inhibitor. Epilepsia 36: 612-626.
41. Dooley JM, Camfeild PR, Smith E, Langevin P, Ronen G. (1999) Topiramate in intractable childhood onset epilepsy - a cautionary note. Can J Neurol Sci 26: 271-273.
42. Yeung S, Ferrie CD, Murdoch-Eaton DG, Livingston JH. (2000) Topiramate for drug-resistant epilepsies. Europ J Paediatr Neurol 4: 31-33.
43. Mohamed K, Appleton R, Rosenbloom L. (2000) Efficacy and tolerability of topiramate in childhood and adolescent epilepsy: A clinical experience. Seizure 9: 137-141.
44. Nakken KO, Eriksson A, Lossius R, Johannessen SI. (2003) A paradoxical effect of levetiracetam maybe seen in both children and adults with refractory epilepsy. Seizure 12: 42-46.
45. Aronson JK. (2003) Anecdotes as evidence. Br Med J 326: 1346.